EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

EUDA Health Holdings LimitedNASDAQ: EUDA

Effect of Forex Changes · Q2 FY2026 · quarter ended Jun 2026

Effect of forex changes turns negative

Q2 FY2026 effect of forex changes was -$3.86K, compared with $29.93K a year earlier. Trailing-twelve-month effect of forex changes was $95.09K.

Context

  • Effect of forex changes amounted to 1.3% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Effect of forex changes increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly effect of forex changes holds near -$3.86K or moves back toward the trailing-twelve-month quarterly average of $23.77K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$3.86K+0.0% QoQ
Last fiscal yearDec 2025
$88.49K+187.1% YoY
LTMJun 2026
$95.09K+115863.4% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-112.9%——
1 year+187.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
88.49K USD
Year-over-year change
+187.1%
4-year CAGR
+45.3%

Effect of Forex Changes vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +115863.4% is the highest of 4, against a peer median of +165.9%.
  • Effect of forex changes amounts to 0.8% of revenue for EUDA, versus a peer median of 4.8%.
EUDA Competitors
Effect of Forex Changes for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DTILPrecision BioSciences, Inc.LTM Mar 2026$3.77M USD——8.4%
AMWLAmerican Well CorporationLTM Mar 2026$3.1M USD+1556.1%—1.3%
ZTEKZentek Ltd.LTM Mar 2026CA$980.56K CAD+35.0%—590.4%
ATYRaTyr Pharma, Inc.LTM Mar 2026$477K USD——251.1%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$95.09K USD+115863.4%—0.8%
FONRFONAR CorporationLTM Mar 2026$193 USD+165.9%—0.0%
HYPRHyperfine, Inc.LTM Mar 2026$0 USD——0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD———
Peer median (excluding EUDA) —+165.9%—4.8%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income900.4K(24.95M)(8.44M)(17.6M)(2.77M)
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
Deferred Income Tax(27.68K)(48.23K)0(4.38K)4.38K
Stock-Based Compensation00000
Change in Working Capital1.18M1.12M531.2K194.93K(230.03K)
Accounts Receivables(263.95K)(174.82K)(32.97K)82.35K(166.99K)
Inventory03.69M0(126.27K)45.43K
Accounts Payables1.38M(1.13M)1.27K15.99K(12.95K)
Other Working Capital68.04K(1.27M)562.89K222.86K(95.52K)
Other Non-Cash Items(1.87M)22.18M4.87M15.21M160.35K
Operating Cash Flow443.92K(1.53M)(2.92M)(2.03M)(2.43M)
Capital Expenditures(1.96K)(18.14K)(5)(116.03K)(104.45K)
Acquisitions (Net)(354.23K)(3.41K)016.3K0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(355.08K)(246.66K)5(48.03K)(27.19K)
Investing Cash Flow(356.18K)(268.21K)0(147.77K)(104.45K)
Debt Repayment(6.69K)1.4M1.44M2.16M2.22M
Common Stock Issued01.1M790K50K100K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(161.69K)(9.47K)121.88K115.14K234.46K
Financing Cash Flow(168.37K)2.49M2.35M2.32M2.55M
Effect of Forex Changes19.87K(99.42K)(21.53K)(101.66K)88.49K
Net Change in Cash(60.77K)594.49K(586.93K)40.05K107.54K
Free Cash Flow441.96K(1.54M)(2.92M)(2.15M)(2.53M)

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.